Teresa K. Kimlinger

3.1k total citations
56 papers, 2.1k citations indexed

About

Teresa K. Kimlinger is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Teresa K. Kimlinger has authored 56 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 23 papers in Molecular Biology and 16 papers in Genetics. Recurrent topics in Teresa K. Kimlinger's work include Multiple Myeloma Research and Treatments (31 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). Teresa K. Kimlinger is often cited by papers focused on Multiple Myeloma Research and Treatments (31 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). Teresa K. Kimlinger collaborates with scholars based in United States, China and Czechia. Teresa K. Kimlinger's co-authors include Shaji Kumar, S. Vincent Rajkumar, Thomas E. Witzig, Philip R. Greipp, Michael Timm, John A. Lust, William G. Morice, Jerry A. Katzmann, Jessica Haug and Vijay Ramakrishnan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Teresa K. Kimlinger

55 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teresa K. Kimlinger United States 29 939 817 716 441 415 56 2.1k
Dominique Leroux France 24 880 0.9× 672 0.8× 841 1.2× 660 1.5× 912 2.2× 74 2.4k
Anwar N. Mohamed United States 21 1.0k 1.1× 1.5k 1.9× 531 0.7× 636 1.4× 374 0.9× 70 2.7k
Enrico Tiacci Italy 27 1.1k 1.2× 811 1.0× 703 1.0× 1.1k 2.4× 1.1k 2.5× 77 2.8k
Karin D. Berg United States 18 931 1.0× 635 0.8× 730 1.0× 373 0.8× 380 0.9× 29 2.2k
Alessandra Stacchini Italy 26 508 0.5× 495 0.6× 558 0.8× 637 1.4× 499 1.2× 76 1.9k
Antonella Aiello Italy 26 1.4k 1.5× 324 0.4× 917 1.3× 738 1.7× 1.0k 2.5× 61 3.1k
Yaping Shou United States 25 1.1k 1.2× 1.8k 2.2× 686 1.0× 1.5k 3.3× 439 1.1× 68 3.1k
Robert Coupland Canada 22 429 0.5× 329 0.4× 683 1.0× 477 1.1× 844 2.0× 40 1.7k
Katja Zirlik Germany 25 1.1k 1.2× 437 0.5× 581 0.8× 894 2.0× 707 1.7× 45 2.4k
Luca Agnelli Italy 35 2.0k 2.1× 1.0k 1.3× 749 1.0× 331 0.8× 550 1.3× 92 2.9k

Countries citing papers authored by Teresa K. Kimlinger

Since Specialization
Citations

This map shows the geographic impact of Teresa K. Kimlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa K. Kimlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa K. Kimlinger more than expected).

Fields of papers citing papers by Teresa K. Kimlinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa K. Kimlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa K. Kimlinger. The network helps show where Teresa K. Kimlinger may publish in the future.

Co-authorship network of co-authors of Teresa K. Kimlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa K. Kimlinger. A scholar is included among the top collaborators of Teresa K. Kimlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa K. Kimlinger. Teresa K. Kimlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramakrishnan, Vijay, Kevin C. Miller, Teresa K. Kimlinger, et al.. (2019). Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma. Haematologica. 104(10). 2061–2074. 27 indexed citations
2.
Lasho, Terra L., Christy M. Finke, Teresa K. Kimlinger, et al.. (2014). Expression of CD123 (IL-3R-alpha), a Therapeutic Target of SL-401, on Myeloproliferative Neoplasms. Blood. 124(21). 5577–5577. 18 indexed citations
3.
Galanis, Evanthia, S. Keith Anderson, Joon H. Uhm, et al.. (2013). Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial. Clinical Cancer Research. 19(17). 4816–4823. 127 indexed citations
4.
Ramakrishnan, Vijay, Teresa K. Kimlinger, Jessica Haug, et al.. (2012). Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway. PLoS ONE. 7(11). e50005–e50005. 52 indexed citations
5.
Ramakrishnan, Vijay, Michael Timm, Jessica Haug, et al.. (2011). Sorafenib, a multikinase inhibitor, is effective in vitro against non‐hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin. American Journal of Hematology. 87(3). 277–283. 29 indexed citations
6.
Ramakrishnan, Vijay, Stephen M. Ansell, Janine Haug, et al.. (2011). MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma. Leukemia. 26(2). 340–348. 60 indexed citations
7.
Ramakrishnan, Vijay, Teresa K. Kimlinger, Jessica Haug, et al.. (2010). TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells. American Journal of Hematology. 85(9). 675–686. 49 indexed citations
8.
9.
Ramakrishnan, Vijay, Michael Timm, Janine Haug, et al.. (2009). Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs. Oncogene. 29(8). 1190–1202. 73 indexed citations
10.
Timm, Michael, Teresa K. Kimlinger, Janine Haug, et al.. (2006). Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma. Leukemia. 20(10). 1863–1869. 18 indexed citations
11.
Kimlinger, Teresa K., S. Vincent Rajkumar, Michael Kline, et al.. (2006). Changes in Bone Marrow Plasma Cell Surface Markers Following CD138-Magnetic Bead Based Positive Selection.. Blood. 108(11). 3516–3516. 2 indexed citations
12.
Kurtin, Paul J., et al.. (2005). FISH Is Superior to PCR in Detecting t(14;18)(q32;q21)-IgH/bcl-2 in Follicular Lymphoma Using Paraffin-Embedded Tissue Samples. American Journal of Clinical Pathology. 124(3). 421–429. 6 indexed citations
13.
14.
Dispenzieri, Angela, Thomas E. Witzig, Martha Q. Lacy, et al.. (2004). A Phase II Trial of Gleevec™ in Patients with Refractory/Relapsed Myeloma.. Blood. 104(11). 2420–2420. 2 indexed citations
15.
Pardanani, Animesh, Terra L. Reeder, Teresa K. Kimlinger, et al.. (2003). Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease. Leukemia Research. 27(8). 739–742. 32 indexed citations
16.
17.
Timm, Michael, Teresa K. Kimlinger, Curtis A. Hanson, & Thomas E. Witzig. (1998). Measurement of the Cell Proliferation Rate of Bone Marrow Erythroid Precursors by Flow Cytometry: Initial Applications to Multiple Myeloma. Leukemia & lymphoma. 30(3-4). 353–359. 3 indexed citations
18.
Kimlinger, Teresa K. & TE Witzig. (1997). Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma. Bone Marrow Transplantation. 19(6). 553–556. 23 indexed citations
19.
Gonchoroff, Nick J., John J. Ryan, Teresa K. Kimlinger, et al.. (1990). Effect of sonication on paraffin‐embedded tissue preparation for DNA flow cytometry. Cytometry. 11(5). 642–646. 33 indexed citations
20.
Lawson, G M, J A Katzmann, Teresa K. Kimlinger, & John F. O’Brien. (1985). Isolation and preliminary characterization of a monoclonal antibody that interacts preferentially with the liver isoenzyme of human alkaline phosphatase.. Clinical Chemistry. 31(3). 381–385. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominique Leroux Breakdown of academic impact, for papers by Anwar N. Mohamed Breakdown of academic impact, for papers by Enrico Tiacci Breakdown of academic impact, for papers by Karin D. Berg Breakdown of academic impact, for papers by Alessandra Stacchini Breakdown of academic impact, for papers by Antonella Aiello Breakdown of academic impact, for papers by Yaping Shou Breakdown of academic impact, for papers by Robert Coupland Breakdown of academic impact, for papers by Katja Zirlik Breakdown of academic impact, for papers by Luca Agnelli
Rankless by CCL
2026